Therefore, it is recommended to use panels consisting of at least two carcinoma markers (such as pCEA BER-EP4, MOC-31, Claudin 4, HEG1) and two mesothelial markers (such as WT1, calretinin, CK5/6, D2-40) [3]. This evidence concerns the gene CALB2 and carcinoma.